Fatal myelotoxicity after azathioprine treatment

Nucleosides, Nucleotides and Nucleic Acids

Volumn 27, Issue 6-7, 2008, Pages 661-665

  Slanar O ^a,c   Chalupna P ^a   Novotny A ^a   Bortlik M ^b   Krska Z ^a   Lukas M ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b ISCARE as   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Azathioprine; Myelotoxicity; Pharmacogenetics; Poor metabolizer; Thiopurine S methyltransferase; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CIPROFLOXACIN; CLINDAMYCIN; FLUCONAZOLE; GROWTH FACTOR; MEROPENEM; MESALAZINE; METHYLPREDNISOLONE; METRONIDAZOLE; PREDNISOLONE; THIOPURINE METHYLTRANSFERASE; VANCOMYCIN;

ADD ON THERAPY; ADULT; ALLELE; BONE MARROW TOXICITY; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ENZYME ACTIVITY; GAS GANGRENE; GENETIC SCREENING; HOMOZYGOSITY; HUMAN; LABORATORY TEST; MALE; PANCYTOPENIA; PARENTERAL NUTRITION; RISK FACTOR; ULCERATIVE COLITIS;

ADULT; AZATHIOPRINE; BONE MARROW; COLITIS, ULCERATIVE; DRUG TOXICITY; FATAL OUTCOME; GAS GANGRENE; HOMOZYGOTE; HUMANS; MALE; METHYLTRANSFERASES; PANCYTOPENIA;

EID: 46749128131     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770802143905     Document Type: Conference Paper

References (12)

1. Yates, C.R.; Krynetski E.Y.; Loennechen T.; Fessing M.Y.; Tai H.L.; Pui C.H.; Relling M.V.; Evans W.E. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann. Intern. Med., 1997, 126, 608-614.
2. Burke, M.P.; Opeskin K. Nontraumatic clostridial myonecrosis. Am. J. Forensic Med. Pathol., 1999, 20, 158-162.
3. Stevens, D.L.; Musher D.M.; Watson D.A.; Eddy H.; Hamill R.J.; et al. Spontaneous, nontraumatic gangrene due to Clostridium septicum. Rev. Infect. Dis., 1990, 12, 286-296.
4. Valentine, E.G.: Nontraumatic gas gangrene. Ann. Emerg. Med. 1997, 30, 109-111.
5. Headley, A.J. 2003. Necrotizing soft tissue infections: a primary care review. Am. Fam. Phys., 68, 323-328.
6. Weinshilboum, R. Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase. Drug Metab. Dispo., 2001, 29, 601-605.
7. Gearry, R.B.; Barclay M.L.; Burt M.J.; Collett J.A.; Chapman B.A.; et al. Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease. Aliment. Pharmacol. Ther., 2003, 18, 395-400.
8. Reuther, L.O.; Sonne J.; Larsen N.E.; Larsen B.; Christensen S.; et al. Pharmacological monitoring of azathioprine therapy. Scand. J. Gastroenterol., 2003, 38, 972-977.
9. Reuther, L.O.; Vainer B.; Sonne J.; Larsen N.E. Thiopurine methyltransferase (TPMT) genotype distribution in azathioprine-tolerant and -intolerant patients with various disorders. The impact of TPMT genotyping in predicting toxicity. Eu.r J. Clin. Pharmacol., 2004, 2509, 797-801.
10. Zelinkova, Z.; Derijks L.J.; Stokkers P.C.; Vogels E.W.; van Kampen A.H.; et al. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression. Clin. Gastroenterol. Hepato., 2006, 4, 44-49.
11. Gisbert, J.P.; Nino P.; Rodrigo L.; Cara C.; Guijarro L.G. Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients.Am. J. Gastroenterol., 2006, 101, 2769-2776.
12. Colombel, J.F.; Ferrari N.; Debuysere H.; Marteau P.; Gendre J.P.; et al. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology, 2000, 118, 1025-1030.